Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface by Laventie, Benoit-Joseph (author) et al.
Residues Essential for Panton-Valentine Leukocidin S
Component Binding to Its Cell Receptor Suggest Both
Plasticity and Adaptability in Its Interaction Surface
Benoit-Joseph Laventie1¤, Fre´de´ric Gue´rin2,3, Lionel Mourey2,3, Mira Y. Tawk1, Emmanuel Jover1,
Laurent Maveyraud2,3*, Gilles Pre´vost1*
1Universite´ de Strasbourg-CHRU, Fe´de´ration de Me´decine Translationnelle de Strasbourg, EA 7290 Virulence bacte´rienne pre´coce, Institut de Bacte´riologie, Strasbourg,
France, 2 Institut de Pharmacologie et Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS), Toulouse, France, 3Universite´ de Toulouse,
Universite´ Paul Sabatier, IPBS, Toulouse, France
Abstract
Panton-Valentine leukocidin (PVL), a bicomponent staphylococcal leukotoxin, is involved in the poor prognosis of
necrotizing pneumonia. The present study aimed to elucidate the binding mechanism of PVL and in particular its cell-
binding domain. The class S component of PVL, LukS-PV, is known to ensure cell targeting and exhibits the highest affinity
for the neutrophil membrane (Kd,10210 M) compared to the class F component of PVL, LukF-PV (Kd,1029 M). Alanine
scanning mutagenesis was used to identify the residues involved in LukS-PV binding to the neutrophil surface. Nineteen
single alanine mutations were performed in the rim domain previously described as implicated in cell membrane
interactions. Positions were chosen in order to replace polar or exposed charged residues and according to conservation
between leukotoxin class S components. Characterization studies enabled to identify a cluster of residues essential for LukS-
PV binding, localized on two loops of the rim domain. The mutations R73A, Y184A, T244A, H245A and Y250A led to
dramatically reduced binding affinities for both human leukocytes and undifferentiated U937 cells expressing the C5a
receptor. The three-dimensional structure of five of the mutants was determined using X-ray crystallography. Structure
analysis identified residues Y184 and Y250 as crucial in providing structural flexibility in the receptor-binding domain of
LukS-PV.
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Introduction
Staphylococcus aureus largely relies on the secretion of toxins and
other virulence factors such as superantigens and proteases for its
virulence, targeting various actors of innate immunity [1,2].
Staphylococcal leukotoxins, a subfamily of pore-forming toxins,
appear to simultaneously confer to S. aureus high virulence and
protection against the host’s immune system. With the exception
of a-hemolysin, which is homo-heptameric [3], leukotoxins are
bipartite toxins, formed by the non-covalent association of two
distinct proteins, a class S and a class F component of
approximately 31 and 34 kDa, respectively, into a likely octameric
species [4,5,6,7]. To date, 7 bipartite leukotoxins have been
identified in S. aureus: Panton-Valentine leukocidin [8], LukM/
LukF’-PV [9], two c-hemolysins [10,11], LukE/LukD [12] and a
variant thereof [13], and more recently, LukH/LukG [14] also
named LukAB [15]. S. intermedius has also been shown to express a
LukS-I/LukF-I leukotoxin, [16], while certain related genes can be
found in other Staphylococcus species.
Four of these leukotoxins are involved in human pathogenicity.
Panton-Valentine leukocidin (PVL) is associated with necrotizing
skin infections, such as boils [17,18], and plays an important role
in the poor prognosis of necrotizing pneumonia [19,20,21]. While
the two c-haemolysins HlgA/HlgB and HlgC/HlgB are not
associated with a specific disease, they are nonetheless expressed
by over 99% of S. aureus strains [22,23] and are thought to increase
the severity of the infection [24,25]. LukE/LukD has been
reported as a dermonecrotic toxin and involved in bullous
impetigo [26]. The toxic action of leukotoxins results from a
complex mechanism which has been described in the case of
HlgA/HlgB [7,27,28,29] and is characterized by: (i) binding of the
S class component on the target cell membrane, which requires
the presence of a specific receptor, (ii) recruitment of the F class
component, (iii) dimerization possibly accompanied by conforma-
tional rearrangement, (iv) formation of an octameric prepore, and
(v) pore formation across the membrane. During this process, both
class S and F proteins are faced with a dual environment: a
hydrophilic milieu, when secreted by the bacteria upon infection,
and a hydrophobic milieu, when forming the pore in the
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membrane. Independently of pore formation, leukotoxins are able
to rapidly activate cellular signalization [30,31], including an
increase in intracellular calcium concentration and chemokine
secretion [32].
At the molecular level, sequence identity varies from 55 to 79%
within a given class, when excluding LukH (LukA) or LukG
(LukB). When these proteins are included in the comparison,
sequence identities drop to about 30–34% [14]. Similarity across
classes remains below 30%. The three-dimensional structure of the
soluble forms of several leukotoxin components are known
[33,34,35,36] and display a similar fold, organized around a
central domain formed by two six-stranded antiparallel b-sheets
(Fig. 1). This so-called cap or core b-sandwich domain is the most
conserved region, and is the location where most protein-protein
interactions found in the pre-pore and pore occur. Two additional
structural domains are also found: the rim domain anchors the
protein to the membrane surface [7,37,38,39], while the stem
domain, closely apposed to the core b-sandwich in the soluble form,
contributes two b-strands to the pore b-barrel. Interestingly, the
rim domain is the least conserved domain, possibly resulting in
variable cell specificities, depending on the leukotoxin involved.
PVL displays a narrow cellular spectrum, restricted to human
and rabbit polymorphonuclear neutrophil leukocytes, PMNs,
monocytes, and macrophages [31]. The binding of LukS-PV has
been shown to be a prerequisite for LukF-PV binding and the
subsequent activation of PMNs. Native or recombinant LukS-PV
displays a Kd as low as 0.07 nM on neutrophils and 0.02 nM on
monocytes [31] which is the highest known affinity for leukotoxins.
Since the binding of LukS-PV to the membrane is a saturable
process, the necessary presence of a LukS-PV receptor on the cell
surface was thus proposed [31,40]. This was recently confirmed by
Spaan et al. who showed that the C5a receptor is required for the
binding of LukS-PV to human neutrophils [41]. This receptor is
also likely involved in the binding of HlgC, since both LukS-PV
and HlgC were shown to compete for a common receptor [31]. In
the case of LukE, receptors CCR5, CXCR1 and CXCR2 have
been identified as binding partners on the cell surface [42,43],
whereas LukH/LukG (LukA/LukB) binds to the CD11b subunit
of the integrin Mac-1 [44].
In order to identify the LukS-PV residues involved in binding to
the C5a receptor at the cell surface, an alanine scanning site-
directed mutagenesis strategy was adopted. Indeed, mutation into
alanine is considered to allow good conservation of molecular
structures, whereas the removal of polar or charged residues often
alters the interacting capacity of proteins. Charged or polar
residues from the rim domain or residues that are conserved in
LukS-PV and HlgC, but not in S component of other leukotoxins,
were more specifically targeted. Nineteen residues were selected
and investigated for their ability to bind to neutrophils as well as
activate the latter and form a functional pore. Five of the most
impaired mutants were crystallized and their three-dimensional
structure determined.
Results
Selection of mutated positions
LukS-PV and HlgC were previously shown to display similar
cellular spectra and to compete for a common membrane site
when binding to cells [31]. Moreover, the rim domain was shown
to likely interact with the cell membrane within the pore [7,45].
Therefore, the sequences of the rim domains of class S components
were compared, in order to identify conserved positions in LukS-
PV and HlgC, but not in other class S proteins (Fig. 1A). The rim
domain encompasses three stretches of residues: S56–F76, A160–
S204 and M234–R263, with the least conserved regions being
Y60–R73, F163–E197 and T240–V261, corresponding to loops in
the LukS-PV structure (Fig. 1B, C). Positions corresponding to
polar or charged residues, with their side-chain oriented towards
the exterior of the protein (as depicted on the structure of wild-type
LukS-PV (PDBID 1T5R), Fig. 1C), were thus selected for
mutation as these residues are more likely to be involved in
interactions either with the target cell membrane or with a
receptor at the cell surface.
Production, purification and characterization of LukS-PV
mutants
With the exception of the D195A and R241A mutants, all
proteins were produced and purified to homogeneity, as assessed
by Coomassie-blue stained SDS-PAGE. For the D195A and
R241A mutants, production yields were too low to allow for
purification, likely due to mutation-induced aggregation of the
fusion protein.
Binding capacities of LukS-PV mutants
Binding capacities of wild-type or mutant LukS-PV to hPMNs
were evaluated by competition experiments with a functional
fluorescein-labeled LukS-PV G10C mutant (LukS-PV*). The Kd of
LukS-PV* for hPMNs was measured at 0.06660.005 nM using
flow cytometry (Fig. 2A), which is in good agreement with
previously published data [31]. The concentration of wild-type or
LukS-PV mutants required for 50% inhibition of labeled
competitor binding (EC50) was calculated, allowing to derive Ki
values (Fig. 2B and Table 1).
Among the 17 tested mutations, twelve did not significantly alter
LukS-binding to hPMNs, with the corresponding proteins
displaying a binding capacity only affected by a factor smaller
than 25-fold. The mutants exhibiting significantly decreased
binding abilities with respect to wild-type LukS-PV were: R73A,
Y184A, T244A, H245A, and Y250A, with Ki values ranging from
1.8 to 6.2 nM, i.e. a 69- to 238-fold increase compared to the Ki
value of wild-type LukS-PV. No single mutation was found to
completely prevent binding of LukS-PV (Table 1).
Undifferentiated U937 cells were mostly insensitive to the
binding of LukS-PV, for concentrations of LukS-PV* up to
500 nM, yielding a calculated Kd.20 mM. By contrast, U937 cells
expressing C5aR, the LukS-PV receptor, bound LukS-PV* with a
Kd of 0.32 nM, thus 5-fold higher than for hPMNs. Furthermore,
the five LukS-PV mutants R73A, Y184A, T244A, H245A and
Y250A were strongly affected in their binding to U937-C5aR with
calculated Ki ranging from 4 to 12 nM, compared to 1.12 nM for
wild-type LukS-PV, thus confirming comparable influences of
these mutations to those tested with hPMNs.
Ability of LukS-PV mutants to activate neutrophils
Activation of Fluo3-loaded hPMNs was evaluated by the ability
of LukS-PV mutants to induce variations in intracellular calcium
concentration [40,46]. A limiting concentration of wild-type LukS-
PV or mutants was used (0.02 nM) with an excess of LukF-PV
(10 nM). This concentration of LukF-PV was chosen as it is closed
to the reported Kd value for the binding of LukF-PV to LukS-PV
[47] Wild-type LukS-PV and mutants led to an almost immediate
increase in intracellular calcium concentration. Only four mutants,
R73A, Y184A, T244A and Y250A, displayed an increased lag-
time prior to calcium entry and a significantly reduced calcium
entry slope, i.e. less than 55% of the LukS-PV control (p,0.001,
one-way ANOVA) (Fig. 3 and Table 1). LukS-PV mutants Y181A,
K182A, Y246A and N248A also had a significantly decreased
Leukocidin S Component Essential Binding Residues
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Figure 1. Positions selected for mutations in LukS-PV. A. Sequence alignment of the three stretches of residues constituting the rim domain of
class S components of leukotoxins. Numbering corresponds to the mature LukS-PV protein. Red asterisks indicate positions selected for mutation.
Strictly conserved residues are indicated on a red background, while similar residues in group 1 (LukS-PV and HlgC) or in group 2 (all others) are
Leukocidin S Component Essential Binding Residues
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calcium entry slope, from 65% to 75% of the control (p,0.05,
one-way ANOVA). LukS-PV Y191A was the only mutant to
display a significantly increased ability to activate neutrophils, with
a calcium entry slope of 135% of the control (p,0.01, one-way
ANOVA).
Pore-forming capacity of LukS-PV mutants
The pore-forming ability of the LukS-PV mutants was
investigated by the measurement of ethidium entry through the
pore using flow cytometry. All tested mutants formed pores, most
with a slightly decreased ability (Fig. 4 and Table 1). Four mutants,
R73A, Y184A, T244A and Y250A, had a significantly affected
pore-forming activity, with at least a 50% reduction in ethidium
bromide entry at 30 min. All other mutants had a pore forming
activity close to that observed with wild-type LukS-PV. Interest-
ingly, the LukS-PV Y191A mutant, which already exhibited
increased hPMN activation, also displayed a slightly increased
pore-forming capacity (111%) compared to LukS-PV.
Structure determination of LukS-PV mutants
Six of the seventeen studied mutants were subjected to
structural analysis: Y184A, T244A, H245A, Y246A, N248A,
and Y250A. Crystals were obtained for all of the above but those
obtained for the H245A LukS-PV mutant diffracted very poorly
and were systematically split; therefore, the structure of this
mutant could not be solved.
The T244A, Y246A and N248A mutated proteins crystallized
in identical conditions (50% PEG 200, 0.1 M MES-NaOH,
pH 7.50). The corresponding crystals belonged to the P43212
space group, with similar cell parameters (a = b,94 A˚ and
c,308 A˚) and 4 molecules per asymmetric unit. These crystals
diffracted X-rays at medium resolution (2.50 to 2.80 A˚). Crystals
indicated with red letters. The secondary structure of LukS-PV is indicated above the alignment, colored according to the corresponding structural
domain: b-sandwich (cyan) and rim (purple). GenBank accession numbers are LukS-PV: CAA51251.1, HlgC: AAA26638.1, HlgA: AAA26637.1, LukE:
CAA73667.1, LukE-V: BAB47174.1, LukS-I: CAA55782.1, LukM: BAA97866.1. B. Schematic representation of the three dimensional structure of LukS-PV
[35], PDB entry 1T5R, highlighting the three structural domains: b-sandwich (cyan), stem (orange) and rim (purple). C. Stereo view of the Ca trace of
wild-type LukS-PV. Residues selected for mutations are displayed as sticks and labeled.
doi:10.1371/journal.pone.0092094.g001
Figure 2. Binding properties of LukS-PV* and LukS-PVmutants to hPMNs and U937-C5aR cells. A. Flow cytometry measurement of LukS-
PV* and fluorescein-labeled LukS-PV G10C binding to human PMNs and U937-C5aR cells (n= 3). B. Graphic representation of the Ki values obtained
for wild-type or mutant LukS-PV. The dotted line corresponds to the value of wild-type LukS-PV. Error bars represent the 95% confidence interval.
Statistical analysis: **: p,0.01, ***: p,0.001 (n= 3).
doi:10.1371/journal.pone.0092094.g002
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Table 1. Binding properties as well as cellular and pore-forming activities of wild-type and LukS-PV mutants1.
Mutation Ki695% (pM) ± confidence interval
Relative affinity
to LukS-PV
Ca2+ entry slope
(% of max/s) ± SEM
Ethidium entry (30 min)
(% of control) ± SEM
LukS-PV 2661.1 - 1.460.05 100
(120623) -
T244A2 6,1906560 238 0.5060.093 2565.9
(11,00062,000) (92)
R73A2 5,08061,000 195 0.6660.065 41611
(12,00065,200) (100)
Y250A2 2,9706370 114 0.7760.17 46614
(5,7006680) (48)
Y184A2 1,8006110 69 0.3160.056 1164.3
(4,1006470) (34)
H245A2 1,8006260 69 1.160.059 8066.7
(4,2006900) (35)
R242A 619692 24 1.260.076 8364.3
F260A 427630 16 1.260.11 8862.2
Y246A 365647 14 1.060.098 8066.7
Y181A 155612 6 0.956 0.045 5465.2
N248A 7468.2 2.8 0.9360.078 7767.6
K182A 6865.2 2.6 1.060.062 7963.4
H257A 5664.5 2.2 1.360.12 9665.5
H173A 4561.3 1.7 1.260.073 7365.8
D190A 4462.6 1.7 1.360.04 9063
Q186A 4360.67 1.7 1.160.072 8064.4
Y191A 4162.9 1.6 1.960.16 11162.4
R263A 3861.3 1.5 1.460.068 9062.8
1Ki values, calcium entry slope and ethidium entry at 30 min were obtained for wild-type LukS-PV and all mutants with hPMNs. Ki values with U937-C5aR cells were
obtained for wild-type LukS-PV and for the most affected mutants (values given in parenthesis).
2Mutations causing a significant decrease in LukS-PV affinity for hPMNs (p,0.001, one-way ANOVA with Dunnett’s post test).
doi:10.1371/journal.pone.0092094.t001
Figure 3. Biological activity of LukS-PV and corresponding mutants: rise of cytoplasmic calcium concentration due to human
neutrophil activation. Values represent the calcium entry slope expressed in percent of maximum calcium fluorescence (after neutrophil lysis with
Triton X-100 0.05% v/v) per second. Statistical analysis: ns, non-significant; *, p,0.05; **, p,0.01; ***, p,0.001 (one-way ANOVA with Dunnett’s post
test, n= 6).
doi:10.1371/journal.pone.0092094.g003
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of the Y184A mutant were obtained at a lower pH 6.50, but the
conditions were otherwise identical. The latter belonged to the
P41212 space group with cell parameters a = 104.86 A˚ and
c = 106.87 A˚, 1 molecule per asymmetric unit, and diffracted up
to 2.33 A˚. The Y250A mutant crystallized in 5% PEG 6000,
0.1 M sodium citrate, pH 4.0. Crystals were orthorhombic, space
group P21212, with cell parameters a = 85.30 A˚, b = 84.29 A˚ and
c = 38.09 A˚ and 1 molecule per asymmetric unit. Crystals
diffracted up to 1.55 A˚. Since no crystal was isomorphous to the
crystals of wild-type LukS-PV [35], molecular replacement was
performed in all cases. This allowed the identification of a clear
and unique solution. Refinement statistics are provided in Table 2.
The overall three-dimensional structures of the mutants were
very similar to the wild-type structure. Indeed, all secondary
structure elements were preserved and local differences were only
observed in certain loops (Fig. 5A). The b-sandwich domain was the
most conserved, with r.m.s. deviations after superposition of
equivalent Ca atoms below 0.63 A˚. The stem domain appeared
more flexible with r.m.s. deviations ranging from 0.21 A˚ to
2.21 A˚.
In the case of the rim domain, wild-type LukS-PV and mutants
T244A, Y246A and N248A displayed only small differences, with
r.m.s. deviations comprised between 0.20 A˚ and 0.30 A˚, whereas
the structure of the rim domain of the Y184A and Y250A mutants
were markedly different, with r.m.s. deviations of 1.10 A˚ and
1.28 A˚, respectively, when compared to the wild-type LukS-PV
structure (Fig. 5). These differences were mostly concentrated in
the V169–Q186 and T244–N248 loops, with mutants Y184A and
Y250A being the most divergent. Of particular note, the rim region
was generally associated with weak electron density, and could not
be completely built in most structures, except in the case of the
Y250A mutant.
Discussion
Specific binding of LukS-PV to the surface of human
neutrophils has been shown to require the presence of a functional
C5a receptor [41], and occurs with an apparent affinity varying
between 0.06 to 6 nM depending on the protein purification tag
and the methodology used [31,40,41]. Non-specific binding to
cellular or artificial membranes has also been shown to occur,
however only when using micromolar concentrations of LukS-PV
[48]. All of the experiments described in the present study were
performed at nanomolar concentrations of wild-type or mutant
LukS-PV, ensuring that only specific binding to the surface of
neutrophils, i.e. to the C5a receptor, could occur. This was
confirmed through the use of undifferentiated U937 cells that do
not naturally express C5aR and do not significantly bind LukS-
PV* even at protein concentrations up to 500 nM, whereas this
binding was observed with a Kd of 320 pM with U937 cells
expressing human C5aR.
Among the seventeen LukS-PV mutants investigated, eight
mutants (H173A, Q186A, D190A, Y191A, R242A, H257A,
F260A and R263A) displayed only marginally altered biological
properties. Five mutants (Y181A, K182A, H245A, Y246A and
N248A) were partially affected. Four LukS-PV mutants (R73A,
Y184A, T244A, and Y250) displayed significant alterations for all
measured parameters, i.e. at least 50-fold decrease in affinity for
hPMN membranes, 2-fold decrease in the slope of Ca2+ influx and
2- to 10-fold reduction in pore-forming capacity. The most
dramatically reduced affinity of the LukS-PV mutants for the
hPMN membrane led to a reduced amount of bound leukotoxin,
which resulted in a decreased number of both activated hPMNs
and functional pores. However, none of the studied mutants was
completely inactive. Indeed, the Ki of wild-type LukS-PV was
0.03 nM and even mutants displaying a 200-fold degradation in
binding still displayed a Ki of about 10 nM, resulting in a
dramatically reduced but still recordable biological activity.
Comparable variations of Ki were observed when LukS-PV
mutants were tested for binding to recombinant undifferentiated
U937-C5aR (Figure 2). The absence of measurable binding to
undifferentiated U937 cells indicates that the presence of the C5a
receptor is required for the initial binding of LukS-PV and for
subsequent events of toxin formation.
The rim domain is known to be responsible for the interaction of
leukotoxins with target cell membranes while the structure of the
c-hemolysin pore [7] indicates that the loops extending at the
bottom of the rim domain are likely involved in this interaction. In
LukS-PV, this area would correspond to residues 181–186 and
241–251. Three of the four most sensitive residues (Y184, T244
and Y250) are found in this region, at close distance from each
Figure 4. Pore-forming activity of LukS-PV and corresponding mutants. Flow cytometry analysis of ethidium entry in neutrophils 30 min
after addition of LukS-PV (wild type or mutant, 0.02 nM) in combination with an excess of LukF-PV (10 nM). Neutrophils were incubated with 4 mM
ethidium bromide prior to toxin addition. Values of ethidium entry are expressed as percent of the control (wild type LukS-PV) activity. Statistical
analysis: ns, non-significant; *, p,0.05; **, p,0.01; ***, p,0.001 (one-way ANOVA with Dunnett’s post test, n= 3).
doi:10.1371/journal.pone.0092094.g004
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other (Fig. 1C). Residue R73, the fourth most affected residue, is
located close to the b-sandwich domain (Fig. 1C). In close
proximity to residues Y184, T244 and Y250, residues R242, H245
and Y246 also induced altered biological activities when mutated
to alanine, albeit to a somewhat lesser extent. Binding affinities of
LukS-PV Y184, T244 and Y250 mutants underwent a 14- to 61-
fold decrease with respect to the value obtained for the wild-type
protein. These results hence identify the bottom loop 240–250 as
well as residue Y184 as being crucial for LukS-PV binding to the
target cell membrane. Residues Y184, T244, Y250, R242, H245,
and Y246 are located on poorly conserved regions among
leukotoxins, except between LukS-PV and HlgC. Residues R73,
H245, Y246 and N248 are specific to the two proteins, whereas
Y184 of LukS-PV is replaced by a histidine residue in HlgC
(Figure 1A). In these two proteins, a four-residue insertion is found
in the loop T240–Y250 compared to other class S components.
This loop has furthermore been shown to be essential for c-
hemolysin activity [49] which has a different cell-target spectrum,
although its direct role in LukS-PV and HlgC activity has never
been demonstrated until now. Indeed, our study provides clear
evidence that the corresponding segment in LukS-PV is crucial for
its binding to the C5a receptor. In this region, the only differences
in sequence between Luks-PV and HlgC are located at positions
240 (Thr in LukS-PV and Ile in HlgC), 241 (Arg in LukS-PV and
Lys in HlgC) and 243 (Thr in LukS-PV and Ser in HlgC). This
T240-T243 stretch is strictly conserved among 40 known variants
of LukS-PV. Such differences between LukS-PV, HlgC and other
class S components may contribute to differences in their target
cell spectrum as well as the binding capacities of PVL and HlgC/
HlgB.
The three dimensional structures of five of the seventeen
investigated LukS-PV mutants were obtained: Y184A, T244A,
Y246A, N248A, and Y250A. This provided a unique opportunity
to correlate their altered biological behavior to structural
properties. In order to sample all possible conformations of
LukS-PV, all structures, including the multiple structures resulting
from non-crystallographic symmetry, were superimposed onto the
A-chain of the wild-type LukS-PV structure (PDB entry 1T5R).
With the 13 structures provided by this study, and since there are 8
molecules in the asymmetric unit of the wild-type crystals, 21
structures could be compared (Fig. 5A). The comparison clearly
enabled to identify regions with the highest structural flexibility:
the stem region and the three loops of the rim domain. In the
structure of the soluble form of both S and F leukotoxin
components, the stem region is comprised of a 3-stranded
antiparallel b-sheet and a connecting loop (residues P121–F129
Table 2. Crystallographic data and refinement statistics of the LukS-PV mutants1.
Y184A T244A Y246A N248A Y250A
Crystallization condition
40% PEG 200 NaMES
0.1 M pH 6.50
40% PEG 200 NaMES
0.1 M pH 7.50
40% PEG 200 NaMES
0.1 M pH 7.50
40% PEG 200 NaMES
0.1 M pH 7.50
5% PEG 6000 NaCitrate
0.1 M pH 4.00
Data collection and processing
Beamline ID29 ID23-EH2 ID14-EH1 ID23-EH2 ID14-EH4
Spacegroup P41212 P43212 P43212 P43212 P21212
Cell parameters (A˚) a = 104.87 c = 106.89 a = 94.47 c = 310.31 a = 94.19 c = 306.44 a = 93.99 c = 309.39 a = 85.30 b = 89.29 c = 38.09
Resolution limits (A˚) 47.60–2.20 (2.30–2.20) 46.70–2.75 (2.80–2.75) 47.05–2.50 (2.64–2.50) 46.99–2.80 (2.90–2.80) 30.84–1.55 (1.60–1.55)
Nb. of observations 222,233 (27,688) 231,080 (4,712) 213,925 (28,588) 291,382 (8,514) 299,073 (22,054)
Nb. of unique reflection 30,803 (3,759) 36,657 (1,606) 46,924 (6,622) 34,936 (3,263) 43,049 (3,855)
Multiplicity 7.2 (7.4) 6.3 (2.9) 4.6 (4.3) 8.3 (2.6) 6.9 (3.6)
Completeness 99.8 (99.7) 97.3 (83.0) 96.9 (95.7) 99.1 (94.6) 99.7 (99.9)
Rsym 0.070 (0.915) 0.110 (0.834) 0.149 (0.827) 0.122 (0.649) 0.067 (0.753)
I/s 16.2 (2.7) 15.1 (2.0) 10.0 (1.8) 16.0 (1.9) 18.8 (3.2)
Refinement
Resolution limits (A˚) 47.60–2.20 46.70–2.75 47.05–2.50 46.99–2.80 30.84–1.55
Nb. of reflections 30,803 36,656 46,908 34,936 43,037
Rfactor 0.210 0.198 0.185 0.224 0.167
Rfree 0.218 0.246 0.228 0.245 0.189
Nb. of molecules/A.U. 1 4 4 4 1
Nb. of atoms
Protein 2,171 8,804 8,761 8,719 2,242
Water 106 319 473 96 297
Others 12 none none none 30
R.m.s. deviations
Bond lengths (A˚) 0.010 0.010 0.010 0.008 0.009
Bond angles (u) 1.12 1.21 1.17 1.09 1.06
Peptide v angles (u) 4.14 3.34 3.69 2.79 4.37
PDB ID 4IYT 4IYC 4J0O 4IZL 4IYA
1Numbers in parentheses report statistics for the highest resolution shell.
doi:10.1371/journal.pone.0092094.t002
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in LukS-PV), closely apposed against the b-sandwich domain. Our
comparison of all available structures of the LukS-PV proteins
indicates that this connecting loop is highly flexible. In all
structures, except for the Y250A mutant, electron density was very
weak in this region and the loop could not be built completely.
This structural flexibility is not surprising since the stem region has
to undergo major structural rearrangement when it deploys into
the membrane and contributes two b-strands to the b-barrel pore.
The rim domain is built from three stretches of residues: S56–
P75, A160–H203, and N233–H257 [35]. Both S56–P75 and
N233–H257 segments are comprised of b-strands that extend
from/into the b-sandwich domain. They form a 4-stranded b-sheet
onto which residues A160–H203 are apposed. This latter stretch
of residues includes a small 2-stranded b-sheet (N161–T165 and
G168–G172) and a long loop (H173–H203) that includes three
short helical segments (P188–Y191, D195–E197, and P200–
H203). The conformation of this loop is stabilized by several intra-
loop hydrogen bonds, whereas only a few interactions with the
other regions of the rim domain were found (Fig. 5B). In most
structures of LukS-PV, the rim domain conformation is well
conserved, with the exception of the R241–A250 loop where
certain local variations were observed (Fig. 5A). Other significant
variations in the conformation of the rim domain were only found
in the structure of the Y184A mutant, where residues V179–Q186
were affected (Fig. 5C), as well as in the conformation of the
Y250A mutant, where two loops (V179–Q186 and R241–A250)
showed structural variations (Fig. 5D). For both Y184A and
Y250A mutants, crystallization was achieved in different condi-
tions than those for wild-type LukS-PV and the other mutants,
resulting in a different crystal packing. This alone suggests that the
structures of mutants Y184A and Y250A differ from the others,
preventing crystallization in similar conditions. As the result of the
Y184A mutation, the hydrogen bond found in the wild-type LukS-
PV structure between Y184OH and S249OG was lost, and the
loop was reorganized with a displacement of 6.0 A˚ for the CA
atom at position 184 (Fig. 5C). In the Y250A mutant structure, the
removal of the tyrosine side chain allowed the displacement of the
N248 side chain, which in turn drove the reorganization of
residues R241–Y250. Space was therefore provided for the
displacement of the V179–Q186 loop, which adopted a confor-
mation close to that observed in the case of the Y184A mutant
(Fig. 5D).
The structural variations observed in this study suggest that the
rim domain of LukS-PV may have the ability to easily adapt its
conformation in order to bind to the C5a receptor present in the
target cell membrane. Our results show that the rim domain of
LukS-PV likely displays the required plasticity for these events,
and that tyrosine residues 184 and 250 may be of paramount
importance in this process, since the corresponding mutants are
among the most affected. Moreover, the functional studies
performed herein indicate that loop 240–250 is crucial for the
binding of LukS-PV to C5aR. Indeed, three of the five most
sensitive residues identified (T244, H245 and Y250) are located in
this loop and form a surface that could represent the principal
binding site for the receptor (Figure 6). The fourth most affected
residue, Y184, also interacts with this loop. To date, no natural
mutation of LukS-PV has been reported that would affect its
specific binding to the membrane receptor. Recent results
obtained with LukE have identified regions Q180–A193 and
L234–R268 as essential for LukE/LukD cytotoxicity, but only
region Q180–A193 as being required for binding to CXCR1 and
CXCR2 [43], whereas in the case of LukH (LukA), residue 323
was found to be crucial for binding to CD11b [50] This suggests
that the mechanism of receptor recognition may not be unique
among all leukotoxins. Moreover, binding of the S component of
leukotoxins to its cognate receptor is not sufficient in itself to result
in pore formation, which requires the recruitment of the F
component and the formation of the adequate hetero-oligomer in
order to form the prepore and, eventually, the pore. All of these
steps, which potentially require specific and major interactions of
LukS-PV with the extracellular region of C5aR, remain to be
characterized at the molecular level. Such data along with a better
understanding of these critical steps involved in LukS-PV binding
are of crucial importance for pharmacological purposes.
Experimental Procedures
Bacterial strains and vectors
Escherichia coli XL1 Blue cells [recA1 endA1 gyrA96 thi1 hsdR17
supE44 relA1 lac (F9 proAB lacIqZDM15 Tn10 (tetr))] (Stratagene,
Agilent Technologies, Massy, France) were used as recipient cells
for transformation with recombinant pGEX-6P-1,Panton-Val-
entine leukocidin genes (Genbank:X72700) (GE Healthcare Life
Science, France, [5]). E. coli BL21 [F2, ompT, hsdS (rB2, mB2), gal]
was used for over-expression of the glutathione-S-transferase
(GST),leukotoxin fusion genes, according to the manufacturer’s
instructions (GE-Healthcare).
Alanine scanning site-directed mutagenesis
LukS-PV mutants were constructed by means of the Quick-
Change mutagenesis protocol (Stratagene) using Phusion Hot
Start DNA polymerase (Finnzyme, Espoo, Finland) and dedicated
oligonucleotides as previously described [5]. All mutated genes
were verified by DNA sequencing.
Expression and purification of leukotoxins
Wild-type and mutant leukotoxins were expressed and purified
as previously described [30]. Briefly, recombinant BL21 E. coli cells
were grown in 26TY medium (bacto-tryptone 17 g/l, bacto-yeast
extract 10 g/l, NaCl 5 g/l), and protein expression was induced
with 0.2 mM IPTG. GST-fusion proteins were purified by affinity
chromatography on glutathione-Sepharose 4B (GE Healthcare),
followed by a SP-sepharose cation-exchange run on a Fast Protein
Liquid Chromatography AKTAPurifyer, after removal of the
glutathione S-transferase tag with PreScission protease (GE
Healthcare). The identity and purity of proteins were confirmed
by radial gel immunoprecipitation against native antigens (0.6%
(w/v) agarose in phosphate buffered saline) and 10–15% (w/v)
SDS-PAGE. Proteins were stored at 280uC.
Figure 5. Structural variations of LukS-PV upon mutations in the rim domain. A. Superposition of the Ca trace of all available structures of
LukS-PV proteins, wild-type or mutants. The Y184A mutant structure is represented in green and the Y250A mutant structure in blue. For the other
structures, the three structural domains are highlighted: b-sandwich (cyan), stem (orange) and rim (purple). B. Close-up stereo view of the rim domain
of the LukS-PV wild-type structure, shown as stick (thin for main-chain and thick for side-chains). Residues labeled in red correspond to the most
sensitive position as identified in this work. C. Stereo view of portion of the rim domain of wild-type LukS-PV (purple) and of the Y184A mutant
structure (green). D. Stereo view of portion of the rim domain of wild-type LukS-PV (purple) and of the Y250A mutant structure (blue). Panels B to D,
hydrogen bonds are represented as grey dots, the orientation of the image is the same as in A. Panels C and D, mutated positions are labeled in italic.
doi:10.1371/journal.pone.0092094.g005
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hPMN purification and activation
Blood samples of anonymous healthy volunteer donors were
purchased at the ‘‘Etablissement Franc¸ais du Sang, Strasbourg,
France’’ in accordance with convention nuSG-CLI-003. Human
polymorphonuclear neutrophil leukocytes (neutrophils) were puri-
fied from buffy coats as previously described [47], and suspended
at 56105 cells/ml (unless specified otherwise) in 10 mM HEPES,
140 mM NaCl, 5 mM KCl, 10 mM glucose, 0.1 mM EGTA
pH 7.3. Human PMN activation was monitored by following the
variation in intracellular free Ca2+. Calcium changes were
determined by recording the variations in emitted fluorescence
of Fluo3-loaded neutrophils as previously described [31]. Briefly,
neutrophils were incubated with 2 mM Fluo3-AMH (Molecular
Probes, Eugene, USA) for 45 min at room temperature, then
washed and resuspended twice in HEPES buffer. Five minutes
prior to toxin addition, 1.1 mM CaCl2 was added to hPMN
suspensions (66106 cells/ml). Variations in fluorescence intensity
of Fluo3 were recorded with a spectrofluorometer (Deltascan, PTI,
USA) at lEx = 488 nm and lEm = 530 nm.
Undifferentiated U937 and U937-C5aR cell cultures
Undifferentiated U937 and U937-C5aR cells, which respec-
tively do not express or stably express the C5aR receptor [51],
were a generous gift from Pr. J.A. van Strijp (Utrecht University,
The Netherlands). Cells were cultured as 50 ml suspension at
37uC under a 5% CO2 atmosphere in 250 ml flasks in RPMI-
1640 medium supplemented with 10% (v/v) of decomplemented
fetal calf serum (Life Technologies, Carlsbad, USA) and 0.1% (w/
v) of both penicillin and streptomycin (InVitrogen, Paisley, UK).
Pore formation measurements
Pore formation was revealed by the penetration of ethidium into
cells [52]. Neutrophils (56105 cells/ml) were pre-incubated for
10 min with 4 mM ethidium bromide. Measurements were
initiated directly after the simultaneous addition of 0.1 nM of
the S component and 10 nM of LukF-PV. Ethidium fluorescence
of 36103 hPMNs was measured using a FacSort flow cytometer
(Becton-Dickinson, Le Pont de Claix, France) equipped with a 15-
mW, 488-nm, argon-ion laser. Data were acquired using
CellQuest Pro software (Becton-Dickinson). Ethidium fluorescence
of hPMNs after a 30-min incubation with PVL was calculated and
normalized with respect to the wild-type LukS-PV control. The
results for 3 different donors were averaged and expressed as
percentages of fluorescence values recorded with dead cells.
Baseline values were obtained for each series of data from a
control without addition of toxin, and were systematically
subtracted from the results of other assays.
Leukotoxin binding assays
Kd determination. The dissociation constants, Kd, were
determined using a binding saturation experiment with increasing
concentrations of fluorescein-labeled LukS-PV* (0.01 nM to
10 nM for hPMNs; 0.1 nM to 500 nM for U937 cells), as
previously described [31]. The amount of labeled protein bound to
the cell surface was measured by flow cytometry as cell
fluorescence at lEm = 530 nm and expressed as the percentage
of maximum fluorescence obtained at the highest concentration of
LukS-PV*. Experimental data were fitted using GraphPad Prism
version 5.04 for Windows (GraphPad Software, San Diego, USA).
Kd values were calculated by a non-linear regression using the
‘‘One site - Specific binding’’ equation.
Ki determination. Fluorescein-labeled LukS-PV* (1 nM)
was displaced by increasing concentrations of various non-labeled
LukS-PV or mutants (0.03 nM to 500 nM). The amount of LukS-
PV* bound to the cell surface was measured by flow cytometry as
the amount of cell fluorescence at lEm = 530 nm. Fifty percent
effective concentrations (EC50) were calculated by GraphPad
Prism using the non-linear regression ‘‘one site binding’’ equation.
The equation of Cheng and Prusoff [53] was used to calculate the
inhibition constant, Ki, from the EC50 value (parameters: Kd LukS-
PV* = 0.066 nM; [LukS-PV*] = 1 nM).
Figure 6. Molecular surface of the rim domain of LukS-PV. Residues identified in this study as important for the binding of LukS-PV on the C5a
receptor (Ki increased more than 50 fold upon mutation to Ala) are depicted in red. Mutated residues affecting binding to a lesser extent (i.e. increase
in Ki by a factor between 5 and 50) are depicted in pink whereas residues for which no effect on binding was found upon mutation (increase in Ki less
than 3 fold) are depicted in blue (Table 1). Two orthogonal views around a vertical axis are presented, with the orientation on the left being the same
as in figure 5.
doi:10.1371/journal.pone.0092094.g006
Leukocidin S Component Essential Binding Residues
PLOS ONE | www.plosone.org 10 March 2014 | Volume 9 | Issue 3 | e92094
Ki~
EC50
1z
LukS{PV½ 
Kd
Protein crystallization and structure determination
Proteins were conditioned in 50 mM MES-NaOH buffer,
50 mM NaCl, pH 6.5 at approximately 10 mg/ml. Crystallization
trials were implemented using the sitting drop method and a
NanoDrop ExtY automated crystallization platform (Innovadyne)
at 285 K. Drops were generated by mixing 200 nL of protein
solution to the same volume of crystallization solution (Table 2).
Crystals were cryo-protected by brief immersion in the
crystallization solution supplemented with 20% (v/v) ethylene
glycol before being transferred into a gaseous nitrogen flux at
100 K. All data collections were performed at the European
Radiation Synchrotron Facility (ESRF, Grenoble, France). Data
processing was initially performed using autoPROC [54], and
optimized with XDS [55] and SCALA [56] (Table 2). All
subsequent operations were performed using the CCP4 program
suite [57].
Structures were solved using the molecular replacement
method, using Phaser 2.3 [58], with the structure of the wild-
type LukS-PV as starting model [35]. Refinement was performed
with Buster (GlobalPhasing, UK) and Coot softwares [59]
(Table 2).
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